These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 32356124)
1. Case report: Analysis of BRCA1 and BRCA2 gene mutations in a hereditary ovarian cancer family. Liao Y; Tu C; Song X; Cai L J Assist Reprod Genet; 2020 Jun; 37(6):1489-1495. PubMed ID: 32356124 [TBL] [Abstract][Full Text] [Related]
2. [Comparison of hereditary breast and ovarian cancer syndrome and sporadic ovarian cancer in ovarian cancer BRCA mutations]. Duan RR; Sun LX; Zhao HW Zhonghua Fu Chan Ke Za Zhi; 2021 Nov; 56(11):788-795. PubMed ID: 34823292 [No Abstract] [Full Text] [Related]
3. Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer. Cao WM; Gao Y; Yang HJ; Xie SN; Ding XW; Pan ZW; Ye WW; Wang XJ BMC Cancer; 2016 Feb; 16():64. PubMed ID: 26852015 [TBL] [Abstract][Full Text] [Related]
4. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families. Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231 [TBL] [Abstract][Full Text] [Related]
5. Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers. Gabaldó Barrios X; Sarabia Meseguer MD; Marín Vera M; Sánchez Bermúdez AI; Macías Cerrolaza JA; Sánchez Henarejos P; Zafra Poves M; García Hernández MR; Cuevas Tortosa E; Aliaga Baño Á; Castillo Guardiola V; Martínez Hernández P; Tovar Zapata I; Martínez Barba E; Ayala de la Peña F; Alonso Romero JL; Noguera Velasco JA; Ruiz Espejo F Fam Cancer; 2017 Oct; 16(4):477-489. PubMed ID: 28477318 [TBL] [Abstract][Full Text] [Related]
6. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study. de Juan I; Palanca S; Domenech A; Feliubadaló L; Segura Á; Osorio A; Chirivella I; de la Hoya M; Sánchez AB; Infante M; Tena I; Díez O; Garcia-Casado Z; Vega A; Teulé À; Barroso A; Pérez P; Durán M; Carrasco E; Juan-Fita MJ; Murria R; Llop M; Barragan E; Izquierdo Á; Benítez J; Caldés T; Salas D; Bolufer P Fam Cancer; 2015 Dec; 14(4):505-13. PubMed ID: 26026974 [TBL] [Abstract][Full Text] [Related]
7. A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention. Hanley GE; McAlpine JN; Miller D; Huntsman D; Schrader KA; Blake Gilks C; Mitchell G BMC Cancer; 2018 Mar; 18(1):254. PubMed ID: 29506471 [TBL] [Abstract][Full Text] [Related]
8. Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis. Kwong A; Ng EK; Wong CL; Law FB; Au T; Wong HN; Kurian AW; West DW; Ford JM; Ma ES PLoS One; 2012; 7(9):e43994. PubMed ID: 22970155 [TBL] [Abstract][Full Text] [Related]
9. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients. Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111 [TBL] [Abstract][Full Text] [Related]
10. Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families. Valarmathi MT; Sawhney M; Deo SSV; Shukla NK; Das SN Hum Mutat; 2004 Feb; 23(2):205. PubMed ID: 14722926 [TBL] [Abstract][Full Text] [Related]
11. [Clinical significance and distribution of BRCA genes mutation in sporadic high grade serous ovarian cancer]. Liu WL; Wang ZZ; Zhao JZ; Hou YY; Wu XX; Li W; Dong B; Tong TT; Guo YJ Zhonghua Fu Chan Ke Za Zhi; 2017 Jan; 52(1):26-31. PubMed ID: 28190312 [No Abstract] [Full Text] [Related]
12. Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil. Maistro S; Teixeira N; Encinas G; Katayama ML; Niewiadonski VD; Cabral LG; Ribeiro RM; Gaburo Junior N; de Gouvêa AC; Carraro DM; Sabino EC; Diz MD; Chammas R; de Bock GH; Folgueira MA BMC Cancer; 2016 Dec; 16(1):934. PubMed ID: 27914478 [TBL] [Abstract][Full Text] [Related]
13. Complete BRCA mutation screening in breast and ovarian cancer predisposition families from a North-Eastern Romanian population. Negura L; Uhrhammer N; Negura A; Artenie V; Carasevici E; Bignon YJ Fam Cancer; 2010 Dec; 9(4):519-23. PubMed ID: 20567915 [TBL] [Abstract][Full Text] [Related]
15. Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer. Machackova E; Foretova L; Lukesova M; Vasickova P; Navratilova M; Coene I; Pavlu H; Kosinova V; Kuklova J; Claes K BMC Cancer; 2008 May; 8():140. PubMed ID: 18489799 [TBL] [Abstract][Full Text] [Related]
16. Germline Mutations of BRCA1 and BRCA2 in Korean Ovarian Cancer Patients: Finding Founder Mutations. Choi MC; Heo JH; Jang JH; Jung SG; Park H; Joo WD; Lee C; Lee JH; Lee JM; Hwang YY; Kim SJ Int J Gynecol Cancer; 2015 Oct; 25(8):1386-91. PubMed ID: 26402875 [TBL] [Abstract][Full Text] [Related]
17. Kim DH; Cho CH; Kwon SY; Ryoo NH; Jeon DS; Lee W; Ha JS J Gynecol Oncol; 2018 Nov; 29(6):e90. PubMed ID: 30207098 [TBL] [Abstract][Full Text] [Related]
18. Detection of BRCA1/2 Mutation and Analysis of Clinicopathological Characteristics in 141 Cases of Ovarian Cancer. Li L; Chen F; Lin A; Wang D; Shi Y; Chen G Comput Math Methods Med; 2021; 2021():4854282. PubMed ID: 34721658 [TBL] [Abstract][Full Text] [Related]
19. BRCA1 and BRCA2 mutations in a sample of breast and ovarian cancer families from the Colombian pacific. Cifuentes-C L; Rivera-Herrera AL; Barreto G Colomb Med (Cali); 2019 Sep; 50(3):163-175. PubMed ID: 32284662 [TBL] [Abstract][Full Text] [Related]
20. BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls. Li A; Xie R; Zhi Q; Deng Y; Wu Y; Li W; Yang L; Jiao Z; Luo J; Zi Y; Sun G; Zhang J; Shi Y; Liu J Gynecol Oncol; 2018 Oct; 151(1):145-152. PubMed ID: 30078507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]